FertilitySmart vs. Other Fertility Supplements: What Makes Us Different

Comparing fertility supplements is less about finding "the best" product and more about matching a formulation to the evidence. A well-designed fertility supplement declares every ingredient and dose, uses forms and quantities that mirror published clinical trials, addresses the different nutritional needs of each partner, and avoids marketing language that would not survive a peer-reviewed paper.

This guide sets out the criteria that separate an evidence-informed fertility supplement from the wider market — and then shows, honestly and factually, how FertilitySmart measures up against each one.

KEY TAKEAWAYS
  • A 2020 systematic review in Urology of 17 popular male fertility supplements found that only 17% of ingredients had published randomised trial data showing a positive effect on semen parameters — meaning most of the market is evidence-thin.1
  • A 2023 scoping review in Human Reproduction Open analysed 34 over-the-counter male fertility supplements and reported that only a small minority had been evaluated in good-quality clinical trials of the finished product.2
  • Proprietary blends are the single biggest transparency red flag: without per-ingredient dosing, there is no way to know whether a product matches the clinical trials it claims to rely on.
  • The UK NHS only specifically recommends one preconception supplement — 400 µg folic acid daily — and supports a 10 µg vitamin D supplement from October to early March (and year-round for those at higher risk of deficiency, including people with limited sun exposure or darker skin).3,4
  • His-and-hers formulations exist because sperm and egg biology require different nutrients: men benefit most from zinc, selenium, L-carnitine, and antioxidants, while women benefit from folate, vitamin D, CoQ10, and — in PCOS — myo-inositol.5,6,9
  • The published evidence on fertility supplements is mixed: a 2018 meta-analysis (Salas-Huetos) shows measurable improvement in sperm parameters, while a 2020 randomised trial (MOXI) found no sperm or pregnancy benefit from an antioxidant blend — so honest claims matter more than confident ones.5,7
  • Any couple trying for 12 months (or 6 months if the female partner is aged 36 or over) should speak with a GP or fertility specialist before starting or changing supplements.

What makes one fertility supplement different from another?

The meaningful differences between fertility supplements come down to five testable criteria: the nutrient profile (which ingredients and at what dose), the biological rationale for each ingredient, the quality of the clinical evidence, the transparency of the label, and whether the formulation reflects the fact that male and female fertility depend on different nutrients. Price, packaging, and marketing claims tell you very little about any of these.

The first thing to internalise is that the fertility supplement category is unusually uneven in evidence quality. A 2020 systematic review in Urology by Kuchakulla and colleagues analysed the 17 most popular over-the-counter male fertility supplements and identified 90 unique ingredients — of which only 17% had published randomised trial data showing a positive effect on semen parameters.1 Most ingredients sat somewhere between "plausible mechanism" and "no human evidence at all." That context reframes comparison: instead of asking which product has the longest ingredient list, ask which products include the nutrients that actually have evidence behind them, at doses that match the trials in which they were studied.

How should you compare nutrient profiles and dosages?

Compare supplements by checking, for each nutrient, whether the dose matches the dose used in the clinical trials that established any benefit. A supplement containing a nutrient at a fraction of the trial dose may look identical on the label but behave like a placebo in practice. This is the most common failure mode in the supplement category — sub-therapeutic dosing hidden behind an impressive ingredient list.

Typical clinical-trial doses for the most-studied fertility nutrients include 400 µg folic acid daily for neural tube defect prevention (NHS-recommended),3 10 µg (400 IU) vitamin D,3,4 100–300 mg CoQ10 for oocyte mitochondrial support,8 1–2 g L-carnitine for sperm motility,5 10–15 mg zinc, 55–100 µg selenium, and 2 g myo-inositol twice daily for women with polycystic ovary syndrome.5,6 When you compare products, line up the label dose against these clinical benchmarks. A fertility supplement that includes CoQ10 but at, say, 20 mg, is delivering roughly a tenth of the tested dose — the ingredient appears on the label, but the biological effect is unlikely to follow.

Form matters alongside dose. Folate as L-methylfolate (5-MTHF) is sometimes preferred in preconception formulas as the bioactive form the body uses directly, though folic acid remains the form with established neural-tube-defect prevention evidence, and the US Centers for Disease Control and Prevention notes that women with MTHFR variants can still process standard folic acid adequately. CoQ10 comes in ubiquinone and ubiquinol — the latter is better absorbed in older adults. Inositol is best studied as a 40:1 myo-inositol to d-chiro-inositol ratio. A supplement that specifies both the form and the dose gives you the information you need to compare; one that doesn't, doesn't.

What does the clinical evidence actually show?

The evidence on fertility supplements is mixed, and an honest comparison resists treating it as settled either way. The strongest summary data comes from a 2018 systematic review and meta-analysis in Advances in Nutrition by Salas-Huetos and colleagues, which reviewed 28 randomised trials and pooled 15 in quantitative analysis, finding that supplementation with zinc, selenium, omega-3 fatty acids, CoQ10, and carnitines was associated with measurable improvements in sperm concentration, motility, and morphology.5 Among individual ingredients, carnitines (L-carnitine and acetyl-L-carnitine, pooled in the meta-analysis) showed one of the larger reported improvements in progressive motility.

Against that, a 2020 randomised controlled trial led by Steiner and colleagues — the Males, Antioxidants, and Infertility (MOXI) trial — enrolled 171 couples and compared an antioxidant blend (vitamins C, E, D, folic acid, lycopene, zinc, selenium, L-carnitine) with placebo in men with male-factor infertility. The antioxidant blend did not improve sperm concentration, motility, morphology, or DNA integrity at three months, and did not improve clinical pregnancy or live birth rates after six months.7 The 2022 Cochrane review of antioxidants for male subfertility by de Ligny and colleagues pooled 90 studies and more than 10,000 men, and concluded that antioxidant supplementation "may" improve live birth and clinical pregnancy — but that the certainty of the evidence across trials was "low to very low."10

What this means in practice is that fertility supplements are a reasonable component of a preconception plan, particularly where dietary intake is limited or where specific sperm parameters are borderline — but they are not a replacement for a diagnostic workup in couples with clear infertility. Any product that implies certainty the underlying evidence does not support should be treated with caution.

Why does a his-and-hers formulation matter?

A his-and-hers formulation matters because male and female fertility depend on meaningfully different nutrients — and a single unisex prenatal product almost always over-serves one partner and under-serves the other. This is one of the most useful criteria when comparing fertility supplements for couples.

Women in the preconception window benefit most from folate (400 µg daily as folic acid or L-methylfolate), vitamin D, CoQ10, and omega-3 fatty acids, with myo-inositol added when PCOS is suspected.3,6,8 Men benefit most from zinc, selenium, L-carnitine, CoQ10, omega-3s, and vitamin E — the antioxidant and trace-mineral profile that supports spermatogenesis.5 Some nutrients — vitamin D, CoQ10, omega-3s — overlap. But others, like L-carnitine and selenium, have their best evidence specifically in male fertility, while folic acid dosing is specific to women's preconception biology.

When you compare products, a good question is whether the formulation is designed for the partner who will actually take it. A single "his and hers" pill that splits nutrients in half is rarely enough of either. Two separate formulas — one designed around female preconception needs and one around sperm biology — is both a more accurate reflection of the evidence and a more transparent comparison point. Readers exploring a couples-based approach may find the fertility supplements for couples guide a useful companion.

What red flags should you watch for on a label?

The reliable red flags are proprietary blends, unspecified forms, unsupported marketing language, and missing per-partner formulations. Any of these makes evidence-based comparison difficult, and all of them together usually indicate a product written for a marketing brief rather than a clinical one.

Red flag What it looks like Why it matters
Proprietary blend "Fertility Matrix 500 mg" with no per-ingredient breakdown Impossible to verify whether any single ingredient matches its clinical-trial dose
Sub-therapeutic dose CoQ10 at 20 mg, L-carnitine at 100 mg, myo-inositol at 200 mg Clinical trials used 100–300 mg CoQ10, 1–2 g L-carnitine, 4 g myo-inositol — below-trial doses rarely reproduce the published benefit5,6,8
Unspecified nutrient form "Folate" with no mention of folic acid or L-methylfolate; "CoQ10" with no ubiquinone/ubiquinol distinction Different forms have different bioavailability; specification signals the formulator considered it
Superlative claims "The #1", "revolutionary", "clinically proven" (without a trial citation) Regulated health claims should cite the specific trial and the specific outcome — unqualified claims are a compliance and credibility risk
Unisex formula sold to couples One pill marketed for "men and women together" The evidence base for male and female fertility supplements is meaningfully different; unisex formulas cannot match both5,6
Missing third-party testing No statement of GMP certification or independent lab verification The supplement industry is not pre-market regulated; third-party testing is one of the few independent signals of ingredient accuracy

These are the practical criteria that separate an evidence-informed supplement from one that may sound similar on the surface but delivers considerably less.

How does FertilitySmart compare against these criteria?

FertilitySmart offers two separate formulations — Conceive for Women and Conceive for Men — designed around the different nutritional needs of each partner during the preconception window. Applied to the framework above:

  • Nutrient profile and dose. Each formula lists every ingredient with its full per-capsule dose. The women's formula includes folate, vitamin D, CoQ10, and chasteberry (Vitex agnus-castus), with the chasteberry dose aligned to the range used in published clinical trials of premenstrual symptoms and hyperprolactinaemia, where it has the strongest evidence base.11 Because chasteberry has dopaminergic activity, women taking dopamine agonists, hormone replacement therapy, oral contraceptives, or fertility medications should discuss it with their healthcare provider before use. The men's formula includes zinc, selenium, L-carnitine, CoQ10, and vitamin E at doses within the ranges reported in the Salas-Huetos 2018 meta-analysis.5
  • Transparency. There are no proprietary blends. Each ingredient appears with its precise dose on the label so any buyer can line it up against clinical trial dosing, as this guide encourages.
  • Forms. Specific forms (such as methylfolate, ubiquinone CoQ10, and named selenium and zinc salts) are declared, not implied.
  • His-and-hers separation. The two formulas reflect the evidence that male and female preconception nutrition are different — rather than a single product halved between partners.
  • Evidence framing. FertilitySmart describes supplements as supporting reproductive health, not as treatments or cures. The claims on each product page correspond to the nutrients' recognised biological roles, not to promises the wider evidence cannot support.

The point of this comparison is not that FertilitySmart is the only supplement that meets these criteria — other reputable preconception formulas do too. The point is that the criteria themselves are the correct way to compare any fertility supplement, and that the answer you arrive at should be one you can defend with evidence rather than marketing.

Frequently Asked Questions

What should I look for in a fertility supplement label?

Look for every ingredient listed with its exact dose (no proprietary blends), clear nutrient forms (such as L-methylfolate vs. folic acid, or ubiquinone vs. ubiquinol CoQ10), clinical-trial-matched doses for the key nutrients, and a formulation tailored to the partner taking it. A supplement should also state third-party testing or good manufacturing practice (GMP) certification where available.

Are fertility supplements regulated in the UK?

Fertility supplements are regulated as food supplements in the UK under the Food Supplements (England) Regulations 2003 and subsequent amendments. They must be safe for consumption and accurately labelled, but — unlike medicines — they are not required to demonstrate efficacy before being sold. This is why evaluation against clinical-trial evidence is left to the buyer, and why the criteria in this guide matter.

Do I need to take the same fertility supplement as my partner?

No, and in most cases the evidence argues against it. Female preconception nutrition emphasises folate, vitamin D, CoQ10, and — in PCOS — myo-inositol, whereas male preconception nutrition emphasises zinc, selenium, L-carnitine, and antioxidants. A shared unisex formula rarely delivers enough of either profile. Separate his-and-hers products designed around each partner's biology are a better reflection of the research.

Is a more expensive fertility supplement always better?

No. Price reflects branding, ingredient sourcing, packaging, and margin — not evidence. A lower-priced supplement with clear per-ingredient dosing at clinical-trial levels is objectively stronger than a higher-priced one built on a proprietary blend. Cost-per-day can be a useful comparison, but only after the evidence-based criteria have been met.

How long should I take a fertility supplement before expecting any benefit?

Most of the clinical trial data assumes at least three months of continuous supplementation, reflecting the roughly 74-day sperm production cycle and the 85–90-day final window of egg maturation. Benefits reported in studies on sperm parameters typically appear at three to six months, not weeks.5 This is one reason how long fertility supplements take to work is worth understanding before starting.

Can a fertility supplement replace the need for medical advice?

No. Supplements are a preconception support, not a diagnosis or treatment. Couples who have been trying for 12 months (or 6 months if the female partner is aged 36 or over) should be assessed by a GP or fertility specialist, as the UK's NICE fertility guideline (NG257) advises.12 Anyone undergoing fertility treatment, taking prescription medication, or with an existing medical condition should discuss any supplement plan with their fertility specialist or GP first, as some botanical and nutrient ingredients can interact with fertility medications, hormonal treatments, and other prescriptions. A supplement plan is one part of a broader preconception approach that also includes a balanced diet, adequate sleep, stress management, and — where relevant — diagnostic testing.

Supporting Your Fertility with FertilitySmart

Choosing a preconception supplement is a decision best made against evidence-based criteria — transparent dosing, forms that match published trials, and separate formulations that reflect the different biology of each partner.

At FertilitySmart, we offer both fertility supplements for women and fertility supplements for men that contain key nutrients such as folate, CoQ10, vitamin D, zinc, selenium, and L-carnitine, each at doses drawn from the published fertility literature. Explore our range of evidence-based fertility supplements formulated with the nutrients discussed in this guide.

References

  1. Kuchakulla M, Soni Y, Patel P, Parekh N, Ramasamy R. A Systematic Review and Evidence-based Analysis of Ingredients in Popular Male Fertility Supplements. Urology. 2020;136:133–141. doi:10.1016/j.urology.2019.11.007
  2. de Ligny WR, Fleischer K, Grens H, Braat DDM, de Bruin JP. The lack of evidence behind over-the-counter antioxidant supplements for male fertility patients: a scoping review. Hum Reprod Open. 2023;2023(3):hoad020. doi:10.1093/hropen/hoad020
  3. National Health Service (UK). How and when to take folic acid. NHS Medicines Guide. Updated 2025. Available at: https://www.nhs.uk/medicines/folic-acid/how-and-when-to-take-folic-acid/
  4. National Health Service (UK). Vitamin D. NHS Vitamins and Minerals. Updated 2024. Available at: https://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-d/
  5. Salas-Huetos A, Rosique-Esteban N, Becerra-Tomás N, Vizmanos B, Bulló M, Salas-Salvadó J. The effect of nutrients and dietary supplements on sperm quality parameters: a systematic review and meta-analysis of randomized clinical trials. Adv Nutr. 2018;9(6):833–848. doi:10.1093/advances/nmy057
  6. Greff D, Juhász AE, Váncsa S, et al. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2023;21(1):10. doi:10.1186/s12958-023-01055-z
  7. Steiner AZ, Hansen KR, Barnhart KT, et al. The effect of antioxidants on male factor infertility: the Males, Antioxidants, and Infertility (MOXI) randomized clinical trial. Fertil Steril. 2020;113(3):552–560.e3. doi:10.1016/j.fertnstert.2019.11.008
  8. Giannubilo SR, Orlando P, Silvestri S, Cirilli I, Marcheggiani F, Ciavattini A, Tiano L. CoQ10 Supplementation in Patients Undergoing IVF-ET: The Relationship with Follicular Fluid Content and Oocyte Maturity. Antioxidants (Basel). 2018;7(10):141. doi:10.3390/antiox7100141
  9. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447–2469. doi:10.1210/clinem/dgad463
  10. de Ligny W, Smits RM, Mackenzie-Proctor R, et al. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2022;5(5):CD007411. doi:10.1002/14651858.CD007411.pub5
  11. van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med. 2013;79(7):562–575. doi:10.1055/s-0032-1327831
  12. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. NICE Guideline NG257. Published 31 March 2026. Available at: https://www.nice.org.uk/guidance/ng257

Related Reading

Marina Carter, Fertility Health Writer at FertilitySmart

Written by Marina Carter

Marina Carter is the Health & Fertility Writer at FertilitySmart. She has been researching and writing about reproductive health, preconception nutrition, and fertility supplementation for over a decade. Marina translates peer-reviewed fertility research into practical, compassionate content for individuals and couples navigating their path to parenthood. Her work focuses on the intersection of nutritional science, women's health, and men's reproductive wellbeing, with a particular emphasis on evidence-based supplementation, PCOS, egg quality, and sperm health. Marina draws on clinical guidelines from NICE, the WHO, and peer-reviewed systematic reviews to ensure content reflects the current state of the evidence. She is committed to giving readers the information they need to make informed choices without oversimplifying complex topics or making promises the science cannot support. Read Full Bio →